Patents by Inventor Vincent John Corvari

Vincent John Corvari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GIP/GLP1 agonist compositions
    Patent number: 12629404
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Grant
    Filed: November 4, 2025
    Date of Patent: May 19, 2026
    Assignee: ELI LILLY AND COMPANY
    Inventors: Vincent John Corvari, Christopher Sears Minie, Dinesh Shyamdeo Mishra, Ken Kangyi Qian
  • GIP/GLP1 AGONIST COMPOSITIONS
    Publication number: 20260053888
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Application
    Filed: November 4, 2025
    Publication date: February 26, 2026
    Inventors: Vincent John CORVARI, Christopher Sears MINIE, Dinesh Shyamdeo MISHRA, Ken Kangyi QIAN
  • GIP/GLP1 AGONIST COMPOSITIONS
    Publication number: 20250367253
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Application
    Filed: July 22, 2025
    Publication date: December 4, 2025
    Inventors: Vincent John CORVARI, Christopher Sears MINIE, Dinesh Shyamdeo MISHRA, Ken Kangyi QIAN
  • GIP/GLP1 agonist compositions
    Patent number: 12453756
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Grant
    Filed: January 31, 2025
    Date of Patent: October 28, 2025
    Assignee: ELI LILLY AND COMPANY
    Inventors: Vincent John Corvari, Christopher Sears Minie, Dinesh Shyamdeo Mishra, Ken Kangyi Qian
  • GIP/GLP1 agonist compositions
    Patent number: 12453755
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Grant
    Filed: January 25, 2024
    Date of Patent: October 28, 2025
    Assignee: ELI LILLY AND COMPANY
    Inventors: Vincent John Corvari, Christopher Sears Minie, Dinesh Shyamdeo Mishra, Ken Kangyi Qian
  • GIP/GLP1 AGONIST COMPOSITIONS
    Publication number: 20250186544
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Application
    Filed: January 31, 2025
    Publication date: June 12, 2025
    Inventors: Vincent John CORVARI, Christopher Sears MINIE, Dinesh Shyamdeo MISHRA, Ken Kangyi QIAN
  • PRESERVED FORMULATIONS
    Publication number: 20250000950
    Abstract: Described herein are preserved formulations of insulin-Fc fusions. The formulations include insulin-Fc fusions having prolonged pharmacokinetic and pharmacodynamic profiles sufficient for once weekly administration in the treatment of diabetes and are sufficiently stable to allow for storage and use without unacceptable loss of chemical or physical stability.
    Type: Application
    Filed: November 14, 2022
    Publication date: January 2, 2025
    Inventors: David Paul ALLEN, John Michael BEALS, Vincent John CORVARI, Patrick Daniel DONOVAN, Ken Kangyi QIAN, Wei WANG
  • GIP/GLP1 AGONIST COMPOSITIONS
    Publication number: 20240226229
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Application
    Filed: January 25, 2024
    Publication date: July 11, 2024
    Inventors: Vincent John CORVARI, Christopher Sears MINIE, Dinesh Shyamdeo MISHRA, Ken Kangyi QIAN
  • GIP/GLP1 agonist compositions
    Patent number: 11918623
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Grant
    Filed: May 10, 2022
    Date of Patent: March 5, 2024
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Christopher Sears Minie, Dinesh Shyamdeo Mishra, Ken Kangyi Qian
  • THERAPEUTIC ANTIBODY FORMULATION
    Publication number: 20230183334
    Abstract: Stable aqueous pharmaceutical formulations for therapeutic antibodies and methods of using such stable aqueous pharmaceutical formulations.
    Type: Application
    Filed: March 1, 2023
    Publication date: June 15, 2023
    Inventors: Vincent John Corvari, Karthik Pisupati
  • Therapeutic antibody formulation
    Patent number: 11634485
    Abstract: Stable aqueous pharmaceutical formulations for therapeutic antibodies and methods of using such stable aqueous pharmaceutical formulations.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: April 25, 2023
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Karthik Pisupati
  • GIP/GLP1 AGONIST COMPOSITIONS
    Publication number: 20220273762
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Application
    Filed: May 10, 2022
    Publication date: September 1, 2022
    Inventors: Vincent John CORVARI, Christopher Sears MINIE, Dinesh Shyamdeo MISHRA, Ken Kangyi QIAN
  • GIP/GLP1 agonist compositions
    Patent number: 11357820
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: June 14, 2022
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Christopher Sears Minie, Dinesh Shyamdeo Mishra, Ken Kangyi Qian
  • THERAPEUTIC ANTIBODY FORMULATION
    Publication number: 20200262911
    Abstract: Stable aqueous pharmaceutical formulations for therapeutic antibodies and methods of using such stable aqueous pharmaceutical formulations.
    Type: Application
    Filed: February 11, 2020
    Publication date: August 20, 2020
    Inventors: Vincent John Corvari, Karthik Pisupati
  • GIP/GLP1 AGONIST COMPOSITIONS
    Publication number: 20190388502
    Abstract: A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 26, 2019
    Inventors: Vincent John Corvari, Christopher Sears Minie, Dinesh Shyamdeo Mishra, Ken Kangyi Qian
  • IL-17 antibody formulations and methods of treatment using same
    Patent number: 10472416
    Abstract: The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: November 12, 2019
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel Donovan, Aaron Paul Markham
  • IL-17 ANTIBODY FORMULATION
    Publication number: 20180057584
    Abstract: The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing psoriatic arthritis or multiple myeloma.
    Type: Application
    Filed: November 10, 2017
    Publication date: March 1, 2018
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel DONOVAN, Aaron Paul MARKHAM
  • IL-17 antibody formulations and methods of treatment using same
    Patent number: 9845353
    Abstract: The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: December 19, 2017
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel Donovan, Aaron Paul Markham
  • IL-17 ANTIBODY FORMULATION
    Publication number: 20160280781
    Abstract: The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-EL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel DONOVAN, Aaron Paul MARKHAM
  • IL-17 antibody formulation and method of treatment using same
    Patent number: 9376491
    Abstract: The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: June 28, 2016
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel Donovan, Aaron Paul Markham